Home > Events > Chimeric Antigen Receptor T Cells: Clinical Development, FDA Approval, and What’s Coming Next

Events

Loading Events

« All Events

  • This event has passed.

Chimeric Antigen Receptor T Cells: Clinical Development, FDA Approval, and What’s Coming Next

March 29 @ 12:00 pm - 1:00 pm

JOINT BIO-MOLECULAR SEMINAR SERIES

Professor Bruce Levine
Founding Director, Clinical Cell and Vaccine Production Facility
Centre for Cellular Immunotherapies Deputy Director – Technology Innovation and Assessment
Perelman School of Medicine
University of Pennsylvania

“Chimeric Antigen Receptor T Cells: Clinical Development, FDA Approval, and What’s Coming Next”

Details

Date:
March 29
Time:
12:00 pm - 1:00 pm
Event Categories:
,

Venue

Lecture Theatre 4002 (Messel) Sydney Nanoscience Hub
(Enter via Physics Rd) The University of Sydney
Sydney, NSW 2006 Australia
+ Google Map
Phone:
9351 2943
Website:
http://whatson.sydney.edu.au/events/published/sydney-ideas-21-century-medicine-the-future-of-medical-research